Mylan to sell tuberculosis drug in two highest-burden countries for the disease

Otsuka Pharmaceutical and Mylan N.V. have entered into a license agreement between their respective subsidiaries, Otsuka Novel Products GmbH (ONPG) and Mylan Pharmaceuticals Private Limited (Mylan), to commercialize delamanid for the treatment of adults with pulmonary multidrug-resistant tuberculosis (MDR-TB) in low- and middle-income countries.

Read more

Global Market Insights says clinical trial management system market worth $2 billion by 2024

Growing prevalence of chronic diseases, surge in clinical trials outsourcing, rising R&D cost and favorable government initiatives will drive global clinical trial management system market size, according to a report by Global Market Insights.

Read more

What belongs in medical kits for climbers and hikers?

For mountain climbers and hikers, injuries often include broken bones, sprains and skin wounds, but many don’t carry the right supplies for the injuries and illnesses they are most likely to face, a recent study found.

Read more